Dissecting dengue: Innovative model sheds light on confounding immune response
About 40 percent of the global population is at risk for contracting dengue - the most important mosquito-borne viral infection ...
About 40 percent of the global population is at risk for contracting dengue - the most important mosquito-borne viral infection ...
The discovery of these seemingly out-of-place sensing cells may lend insight into possibilities for protecting lung function in people who ...
UMD public health researchers say climate change is impacting disease burden in our backyards Human-induced climate change is disrupting nature's ...
Credit: Jason Koski, Cornell University ITHACA, N.Y. - A new class of biomaterial developed by Cornell researchers for an infectious ...
New therapeutic approach points to potential treatment of liver cancer patients with Hepatitis B virus infectionCredit: Gastroenterology SINGAPORE, 27 March ...
A quarter of people surveyed during active 2018 Ebola outbreak in the Democratic Republic of Congo believed the virus was ...
FINDINGS A preclinical study led by scientists at the UCLA Jonsson Comprehensive Cancer suggests that heating solid tumors during CAR ...
Credit: Photo: Klose/Charité How can we further improve deep brain stimulation and its use in the treatment of neurological disorders? ...
Populations with a high prevalence of AIDS-immunocompromised people are more likely to see the emergence of antibiotic-resistant bacterial infections, according ...
Credit: CDC/ Dr. Erskine Palmer In healthy adults, RSV, or respiratory syncytial virus, feels like the common cold with a ...
Credit: Dr. Anne-Claire Jacomin/University of Warwick Autophagy - the process of recycling cellular material in the body, can help combat ...
Developed through Harvard's Blavatnik Biomedical Accelerator, innovations could lead to novel cell therapies to treat diseaseCredit: Mary Todd Bergman, Harvard ...
Approach developed by Mass. General team may get around problems impeding the use of islet-cell transplants Encapsulating human stem-cell-derived beta ...
InDevR launches first-in-class reagent kit for rapid quantification of N9 in 'pandemic' influenza vaccinesCredit: InDevR BOULDER COLORADO (3/26/19) -- InDevR ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.